Ixabepilone plus capecitabine in metastatic breast cancer patients with reduced performance status previously treated with anthracyclines and taxanes: a pooled analysis by performance status of efficacy and safety data from 2 phase III studies
- DOI
- 10.1007/s10549-010-1251-y
- Published
- 2010-12-03
- Container
- Breast Cancer Research and Treatment
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s10549-010-1251-y,
title = {Ixabepilone plus capecitabine in metastatic breast cancer patients with reduced performance status previously treated with anthracyclines and taxanes: a pooled analysis by performance status of efficacy and safety data from 2 phase III studies},
author = {Henri Roché and Pierfranco Conte and Edith A. Perez and Joseph A. Sparano and Binghe Xu and Jacek Jassem and Ronald Peck and Thomas Kelleher and Gabriel N. Hortobagyi},
year = {2010},
journal = {Breast Cancer Research and Treatment},
doi = {10.1007/s10549-010-1251-y},
url = {https://doi.org/10.1007/s10549-010-1251-y}
}RIS
TY - JOUR TI - Ixabepilone plus capecitabine in metastatic breast cancer patients with reduced performance status previously treated with anthracyclines and taxanes: a pooled analysis by performance status of efficacy and safety data from 2 phase III studies AU - Henri Roché AU - Pierfranco Conte AU - Edith A. Perez AU - Joseph A. Sparano AU - Binghe Xu AU - Jacek Jassem AU - Ronald Peck AU - Thomas Kelleher AU - Gabriel N. Hortobagyi PY - 2010 JO - Breast Cancer Research and Treatment DO - 10.1007/s10549-010-1251-y UR - https://doi.org/10.1007/s10549-010-1251-y ER -
APA
Roché, H., Conte, P., Perez, E. A., Sparano, J. A., Xu, B., Jassem, J., Peck, R., Kelleher, T., & Hortobagyi, G. N. (2010). Ixabepilone plus capecitabine in metastatic breast cancer patients with reduced performance status previously treated with anthracyclines and taxanes: a pooled analysis by performance status of efficacy and safety data from 2 phase III studies. Breast Cancer Research and Treatment. https://doi.org/10.1007/s10549-010-1251-y
Source records
- crossref · retrieved 2026-09-25T22:48:22.535Z